EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design and Synthesis of an Azo Reductase Responsive Flavonol–Indomethacin Hybrid Used for the Diagnosis and Treatment of Colitis

Yaqin Gu, Rui Yang, Jine Chen, Yu Fan, Wenna Xie, Hongyan Wu, Jinfeng Ding

Molecules · 2024

DOI: 10.3390/molecules29174244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Yaqin Gu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jiangsu Vocational College of Medicine, Yancheng 224005, China. Hauptthemen laut MEDLINE: Indomethacin, Flavonols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The"Qinglan Project"of Jiangsu College, Jiangsu Higher Education Institution Innovative Research Team For Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human intestinal bacteria are the primary producers of azo reductase, and the content of azo reductase is closely associated with various intestinal diseases, including ulcerative colitis (UC). The rapid detection of changes in azo reductase levels is crucial for diagnosing and promptly intervening in UC. In this study, a therapeutic agent, FAI, specifically targeting UC, was designed and synthesized. This agent was developed by linking the anti-inflammatory drug indomethacin to flavonols with antioxidant activity via an azo bond (off–on). Breakage of the azo bond breaks results in the release of both fluorophores and drugs, achieving targeted tracing and integrated treatment effects. In vivo and in vitro fluorescence imaging experiments were used to demonstrate the potential of FAI in the diagnosis of UC, together with synergistic therapeutic effects through the release of both fluorophores and anti-inflammatory agents. Therefore, this diagnostic agent shows promise as a potential tool for diagnosing and treating UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndomethacinFlavonolsAnimalsHumansMiceColitis, UlcerativeNitroreductasesDrug DesignAnti-Inflammatory AgentsNADH, NADPH OxidoreductasesDisease Models, Animal

Stichwörter der Autor:innen

azoreductasediagnosisflavonolsindomethacintreatmentulcerative colitis

Substanzen

IndomethacinFlavonolsNitroreductasesazoreductaseAnti-Inflammatory AgentsNADH, NADPH Oxidoreductases

Autor:innen und Institutionen

  • School of Pharmacy, Jiangsu Vocational College of Medicine, Yancheng 224005, China.
  • School of Pharmacy, Nantong University, Nantong 226019, China.

Förderung

  • The"Qinglan Project"of Jiangsu College
  • Jiangsu Higher Education Institution Innovative Research Team For Science and Technology

Zitieren

APA

Gu, Y., Yang, R., Chen, J., Fan, Y., Xie, W., Wu, H., & Ding, J. (2024). Design and Synthesis of an Azo Reductase Responsive Flavonol–Indomethacin Hybrid Used for the Diagnosis and Treatment of Colitis. Molecules. https://doi.org/10.3390/molecules29174244

Vancouver

Gu Y, Yang R, Chen J, Fan Y, Xie W, Wu H, et al. Design and Synthesis of an Azo Reductase Responsive Flavonol–Indomethacin Hybrid Used for the Diagnosis and Treatment of Colitis. Molecules. 2024. doi:10.3390/molecules29174244

BibTeX
@article{Gu2024,
  author = {Gu, Yaqin and Yang, Rui and Chen, Jine and Fan, Yu and Xie, Wenna and Wu, Hongyan and Ding, Jinfeng},
  title = {Design and Synthesis of an Azo Reductase Responsive Flavonol–Indomethacin Hybrid Used for the Diagnosis and Treatment of Colitis},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29174244}
}
Kostenlos starten →